We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kimberly-Clark Up 7% in a Month: Is the Stock Still a Good Buy?
Read MoreHide Full Article
Kimberly-Clark Corporation’s (KMB - Free Report) shares have gained 6.6% in the past month, outpacing the industry and the S&P 500's growth of 0.2% and 1.8%, respectively. The company has outperformed the Consumer Staples sector which posted growth of 2.7%. This growth indicates Kimberly-Clark's ongoing commitment to innovation, operational efficiency and expanding its premium product offerings to meet the evolving demands for health, hygiene and sustainability.
KMB Stock Past Month Performance
Image Source: Zacks Investment Research
The stock last traded at $135.64, maintaining strong upward momentum and price stability, with its current price above 50-day simple moving averages of $130.42. Let us analyze the fundamentals of Kimberly-Clark to understand the key drivers behind its market position and financial resilience.
Decoding KMB’s Strategies
Kimberly-Clark's Powering Care Strategy drives growth, efficiency and organizational alignment. The strategy focuses on three core areas, accelerating innovation, optimizing margins and restructuring for sustainable growth. The company invests in high-growth segments and cutting-edge innovations to enhance productivity. These efforts are designed to strengthen its global leadership position.
Innovation is a central focus of Kimberly-Clark’s Powering Care strategy, with it launching new products across all price tiers. By offering unique, higher-value products, Kimberly-Clark aims to drive premiumization and meet evolving consumer demands, strengthening its brand. This strategy is designed to boost consumer loyalty and drive top-line growth in key categories.
Kimberly-Clark achieved significant market share growth across several key regions in 2024, reinforcing its competitive positioning globally. In North America, the company saw an 80-basis point increase in its weighted market share within personal care categories. In China, Huggies gained 200 basis points, while Andrex and Kleenex saw increases in the United Kingdom. South Korea saw a 400-basis point gain in diapers and strong growth in feminine care was achieved in Australia and Indonesia.
These gains highlight Kimberly-Clark's effective strategy, driven by superior products across the good-better-best price tiers and successful commercial strategies that have strengthened its brand and fostered consumer loyalty.
KMB Stock Valuation
Despite this uptick in the stock price, Kimberly-Clark is currently trading at a discount to its historical and industry benchmarks. KMB’s forward 12-month price-to-earnings multiple is 17.95X, below its median level of 18.5X in the past year and lower than the industry’s multiple of 21.25X. This implies that, relative to its earnings potential, the KMB stock might still be undervalued.
Image Source: Zacks Investment Research
What May Pull Back Kimberly-Clark’s Momentum?
Kimberly-Clark has been battling a dynamic consumer and retail environment, which is putting pressure on its performance. On its fourth-quarter 2024 earnings call, management highlighted that the demand has softened in North America’s professional segment, while in emerging markets, like Southeast Asia and Latin America, economic pressures have led to reduced consumer purchasing frequency, particularly in markets with informal economies.
Kimberly-Clark’s extensive global presence makes it highly susceptible to foreign currency volatility. A stronger U.S. dollar pressures margins, especially when the company is unable to raise prices and pass the impact on to its customers. Currency headwinds have already affected performance, with the fourth quarter of 2024 revenues declining 0.8% year over year to $4.93 billion. Unfavorable foreign exchange rates reduced sales by approximately 1.7%, while the divestiture of the Personal Protective Equipment business contributed to an additional 1.4% decline.
Looking ahead to 2025, the company expects net sales to be adversely impacted by nearly 300 basis points, due to unfavorable currency rates. Operating profit growth is also anticipated to face a 300-basis-point drag from currency fluctuations. Additionally, EPS is expected to reflect an adverse impact of 350-400 basis points from currency translation, including the effect on income from equity interests.
KMB’s Consensus Estimates Showing Downtrend
Reflecting the negative sentiment around KMB, the Zacks Consensus Estimate for the current quarter and fiscal 2025 has seen downward revisions. In the past 30 days, analysts have lowered estimates for the current quarter by 2.5% to $1.92 and for the current fiscal by 0.7% to $7.51 per share.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Image Source: Zacks Investment Research
Kimberly-Clark Stock Analysis
Kimberly-Clark stock has demonstrated solid performance, driven by its strategic focus on innovation and operational efficiency. The company's Powering Care strategy, which emphasizes product premiumization and market expansion, has strengthened its competitive position globally. Despite strong growth in several key regions, challenges like foreign currency volatility and softening demand in some markets could dampen near-term momentum.
While the stock appears undervalued relative to its earnings potential, cautious investors may prefer to wait for more favorable conditions before entering. Current investors may benefit from holding their positions. Kimberly-Clark presently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Ollie's Bargain’s current fiscal-year sales and earnings implies growth of 8.3% and 13.1%, respectively, from the year-ago reported numbers. OLLI delivered an earnings surprise of 5% in the trailing four quarters, on average.
Ulta Beauty, Inc. (ULTA - Free Report) operates as a specialty beauty retailer in the United States. It currently holds a Zacks Rank #2. ULTA delivered a trailing four-quarter earnings surprise of 6.2%, on average.
The Zacks Consensus Estimate for Ulta Beauty’s current fiscal-year sales indicates growth of 0.6% from the year-ago reported numbers.
Arhaus, Inc. (ARHS - Free Report) operates as a lifestyle brand and premium retailer in the home furnishings market in the United States. It carries a Zacks Rank #2 at present. ARHS delivered a trailing four-quarter earnings surprise of 124.5%, on average.
The Zacks Consensus Estimate for Arhaus’ current-quarter sales indicates growth of 2% from the year-ago reported numbers.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Kimberly-Clark Up 7% in a Month: Is the Stock Still a Good Buy?
Kimberly-Clark Corporation’s (KMB - Free Report) shares have gained 6.6% in the past month, outpacing the industry and the S&P 500's growth of 0.2% and 1.8%, respectively. The company has outperformed the Consumer Staples sector which posted growth of 2.7%. This growth indicates Kimberly-Clark's ongoing commitment to innovation, operational efficiency and expanding its premium product offerings to meet the evolving demands for health, hygiene and sustainability.
KMB Stock Past Month Performance
Image Source: Zacks Investment Research
The stock last traded at $135.64, maintaining strong upward momentum and price stability, with its current price above 50-day simple moving averages of $130.42. Let us analyze the fundamentals of Kimberly-Clark to understand the key drivers behind its market position and financial resilience.
Decoding KMB’s Strategies
Kimberly-Clark's Powering Care Strategy drives growth, efficiency and organizational alignment. The strategy focuses on three core areas, accelerating innovation, optimizing margins and restructuring for sustainable growth. The company invests in high-growth segments and cutting-edge innovations to enhance productivity. These efforts are designed to strengthen its global leadership position.
Innovation is a central focus of Kimberly-Clark’s Powering Care strategy, with it launching new products across all price tiers. By offering unique, higher-value products, Kimberly-Clark aims to drive premiumization and meet evolving consumer demands, strengthening its brand. This strategy is designed to boost consumer loyalty and drive top-line growth in key categories.
Kimberly-Clark achieved significant market share growth across several key regions in 2024, reinforcing its competitive positioning globally. In North America, the company saw an 80-basis point increase in its weighted market share within personal care categories. In China, Huggies gained 200 basis points, while Andrex and Kleenex saw increases in the United Kingdom. South Korea saw a 400-basis point gain in diapers and strong growth in feminine care was achieved in Australia and Indonesia.
These gains highlight Kimberly-Clark's effective strategy, driven by superior products across the good-better-best price tiers and successful commercial strategies that have strengthened its brand and fostered consumer loyalty.
KMB Stock Valuation
Despite this uptick in the stock price, Kimberly-Clark is currently trading at a discount to its historical and industry benchmarks. KMB’s forward 12-month price-to-earnings multiple is 17.95X, below its median level of 18.5X in the past year and lower than the industry’s multiple of 21.25X. This implies that, relative to its earnings potential, the KMB stock might still be undervalued.
Image Source: Zacks Investment Research
What May Pull Back Kimberly-Clark’s Momentum?
Kimberly-Clark has been battling a dynamic consumer and retail environment, which is putting pressure on its performance. On its fourth-quarter 2024 earnings call, management highlighted that the demand has softened in North America’s professional segment, while in emerging markets, like Southeast Asia and Latin America, economic pressures have led to reduced consumer purchasing frequency, particularly in markets with informal economies.
Kimberly-Clark’s extensive global presence makes it highly susceptible to foreign currency volatility. A stronger U.S. dollar pressures margins, especially when the company is unable to raise prices and pass the impact on to its customers. Currency headwinds have already affected performance, with the fourth quarter of 2024 revenues declining 0.8% year over year to $4.93 billion. Unfavorable foreign exchange rates reduced sales by approximately 1.7%, while the divestiture of the Personal Protective Equipment business contributed to an additional 1.4% decline.
Looking ahead to 2025, the company expects net sales to be adversely impacted by nearly 300 basis points, due to unfavorable currency rates. Operating profit growth is also anticipated to face a 300-basis-point drag from currency fluctuations. Additionally, EPS is expected to reflect an adverse impact of 350-400 basis points from currency translation, including the effect on income from equity interests.
KMB’s Consensus Estimates Showing Downtrend
Reflecting the negative sentiment around KMB, the Zacks Consensus Estimate for the current quarter and fiscal 2025 has seen downward revisions. In the past 30 days, analysts have lowered estimates for the current quarter by 2.5% to $1.92 and for the current fiscal by 0.7% to $7.51 per share.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Image Source: Zacks Investment Research
Kimberly-Clark Stock Analysis
Kimberly-Clark stock has demonstrated solid performance, driven by its strategic focus on innovation and operational efficiency. The company's Powering Care strategy, which emphasizes product premiumization and market expansion, has strengthened its competitive position globally. Despite strong growth in several key regions, challenges like foreign currency volatility and softening demand in some markets could dampen near-term momentum.
While the stock appears undervalued relative to its earnings potential, cautious investors may prefer to wait for more favorable conditions before entering. Current investors may benefit from holding their positions. Kimberly-Clark presently carries a Zacks Rank #3 (Hold).
Stocks to Consider
Ollie's Bargain Outlet Holdings, Inc. (OLLI - Free Report) operates as a retailer of brand-name merchandise in the United States and currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Ollie's Bargain’s current fiscal-year sales and earnings implies growth of 8.3% and 13.1%, respectively, from the year-ago reported numbers. OLLI delivered an earnings surprise of 5% in the trailing four quarters, on average.
Ulta Beauty, Inc. (ULTA - Free Report) operates as a specialty beauty retailer in the United States. It currently holds a Zacks Rank #2. ULTA delivered a trailing four-quarter earnings surprise of 6.2%, on average.
The Zacks Consensus Estimate for Ulta Beauty’s current fiscal-year sales indicates growth of 0.6% from the year-ago reported numbers.
Arhaus, Inc. (ARHS - Free Report) operates as a lifestyle brand and premium retailer in the home furnishings market in the United States. It carries a Zacks Rank #2 at present. ARHS delivered a trailing four-quarter earnings surprise of 124.5%, on average.
The Zacks Consensus Estimate for Arhaus’ current-quarter sales indicates growth of 2% from the year-ago reported numbers.